FDA approves IPL device to manage dry eye disease Patented Lumenis Optimal Pulse Technology (OPT) becomes the first IPL approved for management of dry eye disease due to MGD, and Lumenis launches OptiLight. Read Full Article Explore Other Resources Dry EyePress PublicationsVision Resource HubDry EyePress PublicationsVision Resource HubRevolutionizing Dry Eye TreatmentDry EyePress PublicationsVision Resource HubDry EyePress PublicationsVision Resource HubLumenis’s OptiPLUS Delivers Clinically Significant Results for DEDBlog PostsDry EyeTreatment TypeVision Resource HubBlog PostsDry EyeTreatment TypeVision Resource HubEnhance Patient Care with the Sequential Use of OptiPLUS & OptiLIGHT PB-00038930 Rev A
Dry EyePress PublicationsVision Resource HubDry EyePress PublicationsVision Resource HubRevolutionizing Dry Eye Treatment
Dry EyePress PublicationsVision Resource HubDry EyePress PublicationsVision Resource HubLumenis’s OptiPLUS Delivers Clinically Significant Results for DED
Blog PostsDry EyeTreatment TypeVision Resource HubBlog PostsDry EyeTreatment TypeVision Resource HubEnhance Patient Care with the Sequential Use of OptiPLUS & OptiLIGHT